RENALIS GLOFIL HEALTH LTD

What RENALIS GLOFIL HEALTH LTD does

Renalis Glofil Health Ltd is a Liverpool-based, privately held medical technology company building AI-powered clinical decision support tools for kidney injury across the full care continuum. The company was founded by Moses Omughele, who serves as sole founder and CEO, and is registered in England and Wales (Companies House No. 17147097). Its stated addressable population is the 13 million annual kidney injury cases and 1.7 million annual deaths worldwide, with deployment orientation toward both resource-limited Nigerian hospitals and high-resource NHS Trusts.

The Renalis Suite is a single integrated platform comprising five products: an SMS Alert System for community and ward-level clinical alerting that functions on any mobile device over any network; a Mobile Clinical Application for ward clinicians that operates offline; a Hospital Clinical Decision Support system integrating with laboratory and patient record infrastructure; an NHS & International Clinical System designed for EHR-embedded workflows and MHRA/NHS regulatory alignment; and a Continuous Patient Monitor wearable currently at hardware prototype stage targeting 48-hour battery life for ICU environments. AI capabilities are described as context-aware predictive analytics and anomaly detection on laboratory and physiological data, with models stated to be trained on clinical profiles of the target environments, transparent reasoning per recommendation, and jurisdiction-specific data sovereignty. All five products remain in active development or prototype; no commercial deployment has occurred.

The commercial model is enterprise direct sales through demonstration-by-appointment engagement, targeting NHS Trusts, Nigerian Federal Teaching Hospitals, and international hospital systems with subscription-based clinical decision support licensing and hardware sales of the wearable. Pricing is undisclosed, quote-based, and structured as multi-year contracts intentionally designed to remain affordable in low-income settings at scale permanently. Revenue is not disclosed and no customers are referenced; an anchor clinical partnership with a Nigerian Federal Teaching Hospital is in progress for validation and NAFDAC submission, with NAFDAC, MHRA Class IIa, and FDA clearances sequenced across a planned ten-year, three-phase development programme culminating in an exit or public listing targeted at Year 10.

Name

RENALIS GLOFIL HEALTH LTD

Legal name

Renalis Glofil Health Ltd

Website

https://renalisglofilhealth.com

Company type

Private

Founded year

2026

Operating status

Operating

Short description

Renalis Glofil Health Ltd is a Liverpool-based medical technology company developing AI-powered clinical decision support tools for kidney injury across five integrated products, targeting NHS Trusts in the United Kingdom and teaching hospitals in Nigeria with planned US expansion.

Ownership category

akta.pro rank

Product category

Healthcare AI Clinical Decision Support

NAICS

All Other Outpatient Care Centers (621498)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Nephrology Telemedicine Platforms (HLALAGAI)

akta.pro secondary industry

Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ)

Keywords

• Clinical decision support
• Kidney injury detection
• AI healthcare platform
• Patient monitoring wearables
• Acute kidney injury software

Headquarters

HQ city

Birkenhead

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Decision Support Subscriptions: Subscription-based access to the AI-powered clinical decision support platform, including SMS alerting, mobile clinical application, and hospital clinical decision support modules. Pricing designed to remain affordable permanently in low-income settings at scale.
2. Wearable Monitoring Device Sales: Hardware sales of continuous patient monitoring wearable devices for intensive care environments. Target 48-hour battery life with wireless connectivity. In hardware prototype development phase.
3. NHS & International Clinical System Licensing: Clinical decision support system licensing for NHS Trust environments and international hospital systems, integrated into electronic patient record workflows. Requires MHRA Class IIa registration for UK market entry.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Renalis Glofil Health develops the Renalis Suite, an AI-powered clinical decision support platform for kidney injury detection and management spanning the full care continuum. The platform comprises five integrated products: an SMS Alert System that pushes laboratory result notifications to ward staff on any mobile device, a Mobile Clinical Application for offline-capable ward decision support, a Hospital Clinical Decision Support system integrating with electronic patient records, an NHS & International Clinical System compliant with MHRA standards, and a Continuous Patient Monitor wearable device targeting 48-hour battery life for ICU environments. The offering is designed from inception to serve both resource-limited sub-Saharan African hospitals and high-resource NHS/international clinical settings.

Product overview

The Renalis Suite is a unified platform architecture comprising five integrated products spanning the full kidney injury care continuum: (1) SMS Alert System for community and ward-level clinical alerting, (2) Mobile Clinical Application for mobile decision support, (3) Hospital Clinical Decision Support for hospital-wide clinical intelligence, (4) NHS & International Clinical System for NHS Trust and international deployment, and (5) Continuous Patient Monitor as a wearable monitoring device. All five products form a single integrated platform ensuring clinical insight flows seamlessly to the right clinician in the right setting at the right moment.

Differentiator

Problem solved

Functional benefit

Products and services

• SMS Alert System Intelligent alerting system that connects directly to hospital laboratory systems, analyses results in real time, and delivers targeted clinical notifications to ward staff on any mobile device over any network. No smartphone required. Designed for community-level alerting and ward-level clinical notifications in environments with intermittent connectivity. Status: Active Development.
• Mobile Clinical Application Mobile application for ward clinicians presenting patient risk information in a clear, priority-ranked interface. Fully functional without internet connection and designed for the hardware and network conditions found in real clinical environments. Status: Active Development.
• Hospital Clinical Decision Support Comprehensive clinical decision support system for hospital environments integrating with existing laboratory and patient record infrastructure. Provides real-time clinical intelligence to clinical teams across the hospital with full audit and governance capability built in. Status: Active Development.
• NHS & International Clinical System Clinical decision support system built for NHS Trust environments and international hospital systems, integrated directly into existing electronic patient record workflows. Delivers intelligent guidance to clinicians without leaving their clinical system. Designed to meet MHRA, NHS, and international regulatory standards. Status: In Development.
• Continuous Patient Monitor Wearable continuous monitoring device tracking key patient physiological parameters in real time, providing clinical intelligence between scheduled laboratory measurements to detect deterioration at the earliest possible moment. Designed for intensive care environments in both Nigerian hospitals and NHS Trusts with a target 48-hour battery life and wireless connectivity to the clinical platform. Status: Hardware Prototype — In Development.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Nigerian Federal Teaching HospitalcoreStrategic or Co-development Partner · 1 January 2024Anchor clinical partnership with a leading Nigerian Federal Teaching Hospital — one of the country's foremost academic medical institutions. Provides clinical validation environment for Nigerian deployment programme and anchors regulatory submission to NAFDAC. The institution and its Principal Investigators have been identified. Formal agreements are in progress.
• UK Consultant Nephrologists (Scientific Advisory Board)coreStrategic or Co-development PartnerFive UK consultant nephrologists appointed to the Renalis Glofil Health scientific advisory board. They span AKI clinical guideline leadership, NHS critical care nephrology, clinical AI deployment in the NHS, and national renal policy. Provides independent clinical oversight of all product development and validation activities.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Renalytix: Renalytix is the closest direct peer: an AI-enabled kidney diagnostics company (KidneyIntelX) deploying predictive decision support to identify kidney disease risk and progression in clinical settings — comparable product category, customer base (health systems), and AI-on-clinical-data approach.
• InterWell Health: InterWell Health is a kidney-care organisation combining clinical decision support, predictive analytics, and integrated nephrology practice infrastructure — a kidney-focused clinical intelligence peer operating across US provider and payer systems.
• Viz.ai: Viz.ai is an AI clinical decision support platform that integrates into hospital workflows to surface time-critical patient findings — directly comparable on AI-driven, EHR-integrated, time-sensitive clinical decision support delivered to frontline clinicians.
• Strive Health: Strive Health is a kidney-care value-based care platform combining predictive analytics, care coordination, and CKD/ESRD management — directly comparable as a kidney-focused clinical decision support and outcomes company operating across US health systems.
• Somatus: Somatus provides value-based kidney care with proprietary clinical decision support for CKD/ESRD patients across health plans and providers — a kidney-centric care intelligence platform with comparable population-health and risk-prediction orientation.
• Monogram Health: Monogram Health delivers in-home kidney care supported by predictive AI for CKD/ESRD patients — overlapping with Renalis on renal clinical intelligence, dual low- and high-acuity care delivery, and AI-driven deterioration prevention.

Broad incumbents

• DaVita: DaVita is a major US-based dialysis and integrated kidney care provider with significant clinical AI/data initiatives and EHR-integrated workflows — a broad incumbent in renal care with overlap in hospital and outpatient kidney decision support.
• Tempus AI: Tempus AI is a large AI-enabled clinical decision support and precision medicine platform integrating clinical and molecular data into hospital workflows — a broad incumbent with overlapping AI-CDSS hospital-integration capability, though broader in therapeutic scope than Renalis.
• Fresenius Medical Care: Fresenius Medical Care is the world's largest dialysis and kidney-care provider, with broad renal clinical infrastructure across inpatient, outpatient, and home settings — a broad incumbent whose renal care focus and hospital relationships overlap with Renalis's addressable market.

Emerging players

• Outset Medical: Outset Medical develops the Tablo haemodialysis system with integrated EHR connectivity and remote monitoring — a focused emerging player in home/in-centre renal technology with overlap on Renalis's remote patient monitoring and integration themes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RENALIS GLOFIL HEALTH LTD